US Patent 10888613 Method of producing cells resistant to HIV infection
Patent 10888613 was granted and assigned to American Gene Technologies on January, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10888613 Method of producing cells resistant to HIV infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
